<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03604666</url>
  </required_header>
  <id_info>
    <org_study_id>K170702J</org_study_id>
    <nct_id>NCT03604666</nct_id>
  </id_info>
  <brief_title>Follow-up of Elderly Patients in Ambulatory Surgery</brief_title>
  <acronym>PAPA</acronym>
  <official_title>Ambulatory Process of Elderly Patient for Skin and Breast Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of surgical procedures performed in ambulatory hospitalization for cancers of the&#xD;
      skin or breast is increasing for medical and economic reasons. But the protocols of care and&#xD;
      the clinical pathways are poorly adapted for elderly patients with physical or cognitive&#xD;
      impairment.&#xD;
&#xD;
      The goal of this study is to test the impact of an oncology ambulatory surgical care in&#xD;
      patients aged 75 years or older, with breast or skin cancer and treated in Henri Mondor&#xD;
      hospital on the increase in the proportion of patients operated on an outpatient basis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients operated on an outpatient basis</measure>
    <time_frame>3 month</time_frame>
    <description>Test the impact of an oncology ambulatory surgical care in patients aged 75 years or older, with breast or skin cancer and treated in Henri Mondor hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of death</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients converted to conventional care</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the proportion of patients converted to conventional care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of the passage to emergencies</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the passage to emergencies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of not programmed hospitalizations</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the not programmed hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The autonomy Activities of Daily Living (ADL)</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the autonomy (ADL/IADL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The autonomy Instrumental Activities of Daily Living (IADL)</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the autonomy (ADL/IADL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of institutionalization to Long-term care and skilled nursing facilities</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the institutionalization to Long-term care and skilled nursing facilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of passage to Long-term care and skilled nursing facilities</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the passage to Long-term care and skilled nursing facilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of postoperative complications</measure>
    <time_frame>at Day 90</time_frame>
    <description>Test the impact of the new organization of care on the postoperative complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of care</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on the costs of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients' satisfaction (questionnaire) for the prospective part of the study</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on patients' satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's quality of life (EQ50 questionnaire, for the prospective part of the study)</measure>
    <time_frame>at Day 30 and Day 90</time_frame>
    <description>Test the impact of the new organization of care on quality of life (EQ50) (for the prospective part of the study)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Skin Cancer</condition>
  <condition>Surgery</condition>
  <condition>Ambulatory</condition>
  <arm_group>
    <arm_group_label>Health care process with Nurse Navigator</arm_group_label>
    <description>A Nurse Navigator will:&#xD;
Be present at the announcement consultation&#xD;
Give information on the outpatient circuit&#xD;
Offer assistance for patients over 75 years&#xD;
Complete onco-geriatric orientation questionnaires&#xD;
Take care of patients on the ambulatory circuit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care process</arm_group_label>
    <description>Health care process</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Health care process with Nurse Navigator</intervention_name>
    <description>A Nurse Navigator will:&#xD;
Be present at the announcement consultation&#xD;
Give information on the outpatient circuit&#xD;
Offer assistance for patients over 75 years&#xD;
Complete onco-geriatric orientation questionnaires&#xD;
Take care of patients on the ambulatory circuit</description>
    <arm_group_label>Health care process with Nurse Navigator</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 75 years consulting at the dermatological crossroads or &quot;crossroads breast&quot;&#xD;
        and requiring surgery for a cancer of the skin or breast (without reconstruction)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient ≥ 75 years old with breast cancer or skin cancer and requiring surgical&#xD;
             excision: partial mastectomy, lumpectomy, axillary dissection, cutaneous excision,&#xD;
             etc.&#xD;
&#xD;
          -  With an indication of ambulatory care&#xD;
&#xD;
          -  Patient (legal representative or trusted person or member of the family) having been&#xD;
             informed and having given his non-oral objection to his participation in the study&#xD;
&#xD;
          -  Possessing a health insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients reserved for breast reconstruction to the operative gesture of tumor&#xD;
             resection.&#xD;
&#xD;
          -  Patients do not consent to care because of deficient mental state.&#xD;
&#xD;
          -  Formal surgical contraindication due to a pathology medical device does not allow&#xD;
             anesthesia. - Participation in another interventional research or be in the exclusion&#xD;
             period after a previous search, if applicable&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain BOSC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romain BOSC, MD</last_name>
    <phone>0149812533</phone>
    <phone_ext>+33</phone_ext>
    <email>romain.bosc@aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bosc</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Bosc, MD</last_name>
      <phone>01.49.81.25.33</phone>
      <phone_ext>+33</phone_ext>
      <email>romainbosc@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>laetitia Gregoire</last_name>
      <phone>01.49.81.41.64</phone>
      <phone_ext>+33</phone_ext>
      <email>laetitia.gregoire@aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>June 10, 2018</study_first_submitted>
  <study_first_submitted_qc>July 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2018</study_first_posted>
  <last_update_submitted>January 18, 2019</last_update_submitted>
  <last_update_submitted_qc>January 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>Skin cancer</keyword>
  <keyword>Surgery</keyword>
  <keyword>Ambulatory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

